Preventing Venous Thromboembolism in Patients with Cancer
- PMID: 31141644
- DOI: 10.1056/NEJMc1904003
Preventing Venous Thromboembolism in Patients with Cancer
Comment in
-
Preventing Venous Thromboembolism in Patients with Cancer. Reply.N Engl J Med. 2019 May 30;380(22):2181. doi: 10.1056/NEJMc1904003. N Engl J Med. 2019. PMID: 31141645 No abstract available.
-
Preventing Venous Thromboembolism in Patients with Cancer. Reply.N Engl J Med. 2019 May 30;380(22):2181. doi: 10.1056/NEJMc1904003. N Engl J Med. 2019. PMID: 31141646 No abstract available.
Comment on
-
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. N Engl J Med. 2019. PMID: 30511879 Clinical Trial.
-
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
-
Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer.N Engl J Med. 2019 Feb 21;380(8):781-783. doi: 10.1056/NEJMe1816060. N Engl J Med. 2019. PMID: 30786193 No abstract available.
